{"schema_version":"1","generated_at":"2026-11-06T14:37:50.070Z","data_as_of":null,"url":"https://www.findmykol.com/kol/yolande-chen","json_url":"https://www.findmykol.com/kol/yolande-chen/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"yolande-chen","name":"Yolande Chen","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Illinois Chicago","institution_url":"https://www.findmykol.com/institution/university-of-illinois-chicago","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1942661483","openalex":"A5073271050"},"summary":"Yolande Chen is an Oncology physician affiliated with University of Illinois Chicago. OpenAlex indexes 23 publications with 300 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":23,"cited_by_count":300,"h_index":8,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":6,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Tempus AI, Inc","program_year":2024,"amount_usd":142.2,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1942661483"},{"payer":"Intera Oncology, Inc","program_year":2024,"amount_usd":113.95,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1942661483"},{"payer":"PFIZER INC.","program_year":2024,"amount_usd":23.51,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1942661483"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1942661483","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":26.2,"classes_total":2,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":16.7,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":13},{"class":"Gabapentinoids","setting":"prescribed","share_pct":9.5,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":24.6,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":15.9,"drugs":[{"name":"Loperamide","share_pct":100}],"max_beneficiaries":null},{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":8.7,"drugs":[{"name":"Zenpep","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":19,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":19,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":18.6,"facility_pct":81.4},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2015,"last":2019},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K08HL114871","title":"Membrane-Cytoskeletal Remodeling in Platelet Biogenesis","fiscal_year":2019,"amount_usd":"77780","organization":"NORTHWESTERN UNIVERSITY AT CHICAGO","source_url":"https://reporter.nih.gov/quickSearch/K08HL114871"},{"project":"K08HL114871","title":"MEMBRANE-CYTOSKELETAL REMODELING IN PLATELET BIOGENESIS","fiscal_year":2019,"amount_usd":"26419","organization":"UNIVERSITY OF ILLINOIS AT CHICAGO","source_url":"https://reporter.nih.gov/quickSearch/K08HL114871"},{"project":"K08HL114871","title":"Membrane-Cytoskeletal Remodeling in Platelet Biogenesis","fiscal_year":2018,"amount_usd":"103130","organization":"NORTHWESTERN UNIVERSITY AT CHICAGO","source_url":"https://reporter.nih.gov/quickSearch/K08HL114871"}],"source":"grants"},"publications":{"total":23,"shown":5,"withheld":18,"matched_by":"OpenAlex author record","recent":[{"title":"Phase II study of NALIRIFOX (nanoliposomal irinotecan + oxaliplatin with fluorouracil and folinic acid) in advanced unresectable small bowel tumors.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps802","status":"verified"},{"title":"Stereotactic Body Radiation Therapy Facilitating Debulking Surgery in Metastatic VIPoma with Severe Diarrhea and Hypovolemic Shock","year":2025,"journal":"American Journal of Case Reports","source_url":"https://doi.org/10.12659/ajcr.949041","status":"verified"},{"title":"Abstract 6586: Targeting cancer cell dynamin activity in vitro impacts exosome production and cell proliferation","year":2025,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2025-6586","status":"verified"},{"title":"A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyae236","status":"verified"},{"title":"Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report","year":2022,"journal":"World Journal of Clinical Cases","source_url":"https://doi.org/10.12998/wjcc.v10.i20.7124","status":"verified"}],"source":"works"},"contact":{"address_1":"303 E SUPERIOR ST","address_2":"RM 5-220E","city":"Chicago","state":"IL","zip":"606113015","phone":"312-503-3204","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1942661483","source":"identity"},"similar":[{"name":"Jerry Krishnan","slug":"jerry-krishnan","institution":"University of Illinois Chicago","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/jerry-krishnan","json_url":"https://www.findmykol.com/kol/jerry-krishnan/profile.json"},{"name":"John Daugirdas","slug":"john-daugirdas","institution":"University of Illinois Chicago","specialty":"Nephrology","url":"https://www.findmykol.com/kol/john-daugirdas","json_url":"https://www.findmykol.com/kol/john-daugirdas/profile.json"},{"name":"Niranjan Karnik","slug":"niranjan-karnik","institution":"University of Illinois Chicago","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/niranjan-karnik","json_url":"https://www.findmykol.com/kol/niranjan-karnik/profile.json"},{"name":"Oana Danciu","slug":"oana-danciu","institution":"University of Illinois Chicago","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/oana-danciu","json_url":"https://www.findmykol.com/kol/oana-danciu/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"funding":3,"publications":18}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-03-11","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}